Simplexa CMV Kit

Simplexa CMV Kit

Background

Human cytomegalovirus (CMV), a beta herpes virus, is a member of the human herpes virus family. Infection with CMV is common in all human populations and approximately 70% or more of adults are seropositive for CMV antibodies, indicating previous infection with the virus.

As with all herpes viruses, CMV establishes latent infection in the host after recovery from the acute infection. Reactivation of the virus can occur after immunosuppression or other illnesses. CMV in immunocompromised patients is a well-known cause of morbidity and mortality.

Monitoring by quantifying the levels of CMV in blood and plasma is critical for the effective management of these patients, driving changes in immunosuppression regimes, implementation of antiviral therapy or preemptive treatment. Once the diagnosis is made, a test capable of monitoring and quantifying the presence of CMV in blood and plasma is critical for the efficient and effective management of CMV infection in these patients.

Why to choose it

A reliable and accurate assay for quantitation of cytomegalovirus (CMV) nucleic acids in whole blood and plasma specimens.

Benefits

Reliability

The Simplexa CMV Kit has a sensitivity of 713 IU/mL and has been aligned to the World Health Organization (WHO) standard for CMV testing.

SIMPLEXA CMV KIT

For use on

LIAISON MDX

Ordering Info

Click below for more information

DiaSorin Molecular Menu